Question 1

A medical device company uses a commercial off-the-shelf (COTS) software program for managing its training records. The software is not directly used in the manufacturing process but is integral to personnel training and demonstrating compliance with ISO 13485:2016. The Lead Auditor reviews the company's training procedure and notes the procedure indicates the company must perform testing of software used within the QMS, and validation is not required. Which of the following would be the MOST appropriate determination for the Lead Auditor?

Options :

A : Accept the process, as long as the procedure indicates the software is not used in production, testing is sufficient.

B : Accept the procedure, so long as the organization keeps accurate training records, the process is valid.

C : Issue a minor nonconformity, because the software validation procedure has not been followed.

D : Issue a finding, because the company-s documentation lacks justification for using a testing and not a validation approach for training software.

Answer: D

Question 2

During an ISO 13485:2016 audit of a medical device company, the Lead Auditor discovers that the company has implemented a comprehensive training program for its employees. The program covers various aspects of the QMS, including document control, CAPA, and risk management. However, the effectiveness of the training is solely measured through post-training quizzes, with no documented evidence of how the learned knowledge and skills are applied in the employees' actual job performance. As a Lead Auditor, what is your PRIMARY concern?

Options :

A : The lack of a defined process for verifying the effectiveness of the training could lead to employees not applying the learned knowledge and skills in their work, potentially impacting product quality and safety.

B : The exclusive reliance on post-training quizzes is sufficient to demonstrate training effectiveness, as long as the quiz questions are comprehensive and cover all relevant aspects of the QMS.

C : The absence of documented evidence of training effectiveness is not a significant concern, as long as the training program is well-structured and covers all required topics.

D : The company should focus on improving the content of the post-training quizzes to better assess the employees' understanding of the QMS requirements.

Answer: A

Question 3

A medical device company is undergoing an ISO 13485:2016 audit. The company utilizes a contract manufacturer for a critical component of their Class II medical device. The Lead Auditor reviews the company's process for controlling the outsourced process. The quality agreement with the contract manufacturer clearly defines the product specifications, quality requirements, and acceptance criteria. There is evidence of recent performance data trending showing sustained compliance, however, the quality agreement does not define how frequently the quality agreement itself is reviewed or updated. As a Lead Auditor, what is the MOST appropriate determination regarding the company's approach?

Options :

A : The lack of a defined review frequency for the quality agreement is a critical nonconformity and must be cited, as all agreements need to be reviewed and updated annually.

B : The Lead Auditor should verify that there is a process in place to address changes to the contract manufacturer-s processes or requirements that would necessitate an update to the quality agreement.

C : The Lead Auditor should only be concerned with compliance to specifications, quality requirements, and acceptance criteria. The Lead Auditor should not focus on the frequency of reviewing agreements as that is an administrative burden.

D : As long as the medical device manufacturer has evidence to show compliance to specification, there is no need to verify that agreements have a process in place to address changes to the contract manufacturer’s processes or requirements that would necessitate an update to the quality agreement.

Answer: B

Question 4

During an ISO 13485:2016 surveillance audit, a Lead Auditor reviews the management review process of a medical device company. The company conducts management reviews quarterly, as required. However, the Lead Auditor notices that the documented outputs of these reviews consistently lack specific action items with assigned responsibilities and deadlines for addressing identified issues. Which of the following is the MOST significant concern regarding this situation?

Options :

A : The frequency of the management reviews is insufficient to address the company-s needs.

B : The lack of documented action items and responsibilities undermines the effectiveness of the management review process.

C : The documented outputs should also include a review of the company-s financial performance.

D : The management review process is compliant since the company is conducting reviews as frequently as documented.

Answer: B

Question 5

A medical device company has implemented a system for monitoring and measuring key processes within its Quality Management System (QMS). The system generates various performance metrics, which are regularly reviewed by management. However, the Lead Auditor discovers that the company has not established specific, measurable, achievable, relevant, and time-bound (SMART) objectives for these metrics. As a Lead Auditor, what is the MOST significant concern?

Options :

A : The lack of SMART objectives indicates a potential lack of commitment to continual improvement within the QMS.

B : Without SMART objectives, it will be difficult to determine whether the monitoring and measurement system is effective in achieving its intended purpose.

C : The absence of SMART objectives will likely lead to inconsistencies in data collection and analysis across different departments.

D : The company is not fully utilizing the available data to identify areas for improvement and optimize process performance.

Answer: B

Confidently Practice Online with Free ISO-QMS-13485 Exam Cram

Buying Options: